-
1دورية أكاديمية
المؤلفون: Julia Kunz, Christiane Wiedemann, Heidrun Grosch, Katharina Kriegsmann, Stefanie Gryzik, Julia Felden, Michael Hundemer, Huriye Seker-Cin, Miriam Stenzinger, Albrecht Leo, Albrecht Stenzinger, Michael Thomas, Petros Christopoulos
المصدر: Cancers, Vol 14, Iss 11, p 2720 (2022)
مصطلحات موضوعية: ALK+ NSCLC, alectinib, anemia, hemolysis, acanthocytosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Lino Möhrmann, Lysann Rostock, Małgorzata Oleś, Arne Jahn, Marie Arlt, Nagarajan Paramasivam, Korinna Jöhrens, Luise Rupp, Marc Schmitz, Daniela Richter, Sebastian Uhrig, Martina Fröhlich, Barbara Hutter, Jennifer Hüllein, Elena E. Wolf, Dorothea Hanf, Laura Gieldon, Simon Kreutzfeldt, Christoph E. Heilig, Veronica Teleanu, Daniel B. Lipka, Andreas Mock, Ivan Jelas, Damian T. Rieke, Marcel Wiesweg, Melanie Boerries, Anna L. Illert, Alexander Desuki, Thomas Kindler, Angela M. Krackhardt, C. Benedikt Westphalen, Heidrun Grosch, Leonidas Apostolidis, Albrecht Stenzinger, Irina A. Kerle, Christoph Heining, Daniel Hübschmann, Evelin Schröck, Stefan Fröhling, Hanno Glimm
المصدر: Cancer Research. 83:926-926
مصطلحات موضوعية: Cancer Research, Oncology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::31c9b0337370ed3d7fafc2c061b717de
https://doi.org/10.1158/1538-7445.am2023-926 -
3
المؤلفون: D. Ross Camidge, Teresa Moran, Ingel Demedts, Heidrun Grosch, Kathryn Mileham, Julian Molina, Oscar Juan-Vidal, Gerold Bepler, Jonathan W Goldman, Keunchil Park, Johan Wallin, Sameera R Wijayawardana, Xuejing Aimee Wang, Volker Wacheck, Egbert Smit
المساهمون: CCA - Cancer Treatment and quality of life
المصدر: Clinical Lung Cancer, 23(4), 300-310. Elsevier
Clinical Lung Cancer, 23(4), 300-310. CIG MEDIA GROUP, LP
Clinical Lung Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
CLINICAL LUNG CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Camidge, D R, Moran, T, Demedts, I, Grosch, H, Mileham, K, Molina, J, Juan-Vidal, O, Bepler, G, Goldman, J W, Park, K, Wallin, J, Wijayawardana, S R, Wang, X A, Wacheck, V & Smit, E 2022, ' A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib ', Clinical Lung Cancer, vol. 23, no. 4, pp. 300-310 . https://doi.org/10.1016/j.cllc.2022.03.003مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Hepatocyte growth factor, Cancer Research, Lung Neoplasms, EGFR, Antibodies, Monoclonal, Humanized, Immunohistochemistry, LY2875358, respiratory tract diseases, ErbB Receptors, Erlotinib Hydrochloride, Oncology, Emibetuzumab, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Mutation, MET, Humans, neoplasms, Retrospective Studies
وصف الملف: application/pdf
-
4
المؤلفون: Volker Wacheck, Johan Wallin, Nicolas Girard, Matteo Brighenti, Christian Schumann, Adolfo Favaretto, Chun-Ming Tsai, Giorgio V. Scagliotti, M Kimmich, Te Chun Hsia, Eun Kyung Cho, Kambiz Mansouri, Sameera R. Wijayawardana, Aaron M Gruver, Heidrun Grosch, Denis Moro-Sibilot, Jens Kollmeier, Xuejing Aimee Wang, Gee-Chen Chang
المصدر: Transl Lung Cancer Res
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Population, Phases of clinical research, NSCLC, Antibodies, Monoclonal, Humanized, Antibodies, Disease-Free Survival, Erlotinib Hydrochloride, 03 medical and health sciences, 0302 clinical medicine, Gefitinib, Acquired resistance, Antibody, First-line EGFR mutation, MET, Antineoplastic Combined Chemotherapy Protocols, ErbB Receptors, Humans, Mutation, Protein Kinase Inhibitors, Internal medicine, Monoclonal, medicine, Osimertinib, education, Humanized, neoplasms, EGFR inhibitors, education.field_of_study, business.industry, Hazard ratio, respiratory tract diseases, Editorial Commentary, 030104 developmental biology, Onartuzumab, 030220 oncology & carcinogenesis, Erlotinib, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ffabff039955c1d797cd283c0b4bf63
https://doi.org/10.1016/j.jtho.2019.10.003 -
5
المؤلفون: Heidrun Grosch
المصدر: Pneumo News. 11:29-36
مصطلحات موضوعية: Gynecology, medicine.medical_specialty, business.industry, Medicine, business
-
6
المؤلفون: Alexander Marx, Farastuk Bozorgmehr, Thomas Muley, Hauke Winter, Michael Thomas, Sonja Kobinger, Petros Christopoulos, Esther Herpel, Heidrun Grosch, Michael Meister, Paul Fisch, Inn Chung, Ralf J. Rieker
المصدر: Histopathology. 73:1040-1043
مصطلحات موضوعية: 0301 basic medicine, Pathology, medicine.medical_specialty, Histology, Thymoma, CD3 Complex, Lymphocyte, CD247, T-cell receptor, Thymus Neoplasms, General Medicine, Biology, medicine.disease, Pathology and Forensic Medicine, 03 medical and health sciences, Thymocyte, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, medicine, Humans, Immunohistochemistry, 030215 immunology
-
7
المؤلفون: K Hornemann, Harland S. Winter, EL Bulut, Christiane Grünewald, Martin E. Eichhorn, Heidrun Grosch, Florian Eichhorn
المصدر: Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c7f7a39af9389c1fcfd1ab29dea7e79c
https://doi.org/10.1055/s-0038-1668371 -
8
المؤلفون: Te Chun Hsia, Johan Wallin, Eun Kyung Cho, Nicolas Girard, Denis Moro-Sibilot, Xuejing Aimee Wang, Gee-Chen Chang, Matthew Brighenti, Kambiz Mansouri, Adolfo Favaretto, Chun-Ming Tsai, Giorgio V. Scagliotti, Heidrun Grosch, Jens Kollmeier, Aaron M Gruver, Christian Schumann, Sameera R. Wijayawardana, M Kimmich, Volker Wacheck
المصدر: Journal of Clinical Oncology. 35:9019-9019
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, non-small cell lung cancer (NSCLC), Phases of clinical research, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Emibetuzumab, biology, business.industry, medicine.disease, Disease control, Surgery, First line treatment, 030104 developmental biology, 030220 oncology & carcinogenesis, Monoclonal, biology.protein, Erlotinib, Antibody, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::83a903daa5b29940500254fbc96c9191
https://doi.org/10.1200/jco.2017.35.15_suppl.9019 -
9
المؤلفون: Oscar Juan Vidal, Kathryn Finch Mileham, Ingel K. Demedts, Jonathan W. Goldman, Julian R. Molina, Heidrun Grosch, Xuejing Aimee Wang, Teresa Moran, Conrad R. Lewanski, Keunchil Park, Gerold Bepler, Sameera R. Wijayawardana, D. Ross Camidge, Volker Wacheck, Johan Wallin, Egbert F. Smit, Jean-Pierre Di Mercurio
المصدر: Journal of Clinical Oncology. 34:9070-9070
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Phases of clinical research, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Acquired resistance, 030220 oncology & carcinogenesis, Internal medicine, Monoclonal, biology.protein, medicine, In patient, Emibetuzumab, Erlotinib, Antibody, Open label, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9b40894f93357d2e14d5e98794dca693
https://doi.org/10.1200/jco.2016.34.15_suppl.9070
Full Text Finder 
Full Text via ClinicalKey 
Find this article in full text from Springer Verlag.